The world of hematology is constantly evolving, with breakthroughs and advancements that are improving the lives of patients dealing with various hematologic conditions. If you’re passionate about staying at the forefront of these developments, mark your calendars for Friday, December 8th, 2023, and join us in beautiful San Diego for a day filled with educational events that will unveil the latest hematologic advancements. What’s even better is that you don’t need to register for the ASH Annual Meeting to attend these sessions. All six events are free, accredited for CME/CE, and come with refreshments. Secure your seat today and embark on an exciting journey into the world of hematology breakthroughs.
Event Details
Date: Friday, December 8, 2023 Time: 6 Exciting Events from 7:00 AM to 5:30 PM PT Location: Marriott Marquis San Diego Marina, 333 W Harbor Dr., San Diego, California
Event Highlights
Morning Session (7:00 AM – 10:30 AM PT)
The day kicks off with a breakfast session titled “The Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.” Led by experts in the field, this session will explore crucial topics such as NCCN guidelines, regimen choices, the use of BTK inhibitors, and CAR T-cell therapy. You’ll gain practical insights into effective CLL management and stay updated with the latest ASH 2023 CLL abstracts.
Morning Sessions (11:00 AM – 2:30 PM PT)
The mid-morning session offers an interactive twist with “An MCL Quiz Game: Experts Review New and Emerging Therapies to Optimize Clinical Outcomes.” This engaging format will delve into the changing landscape of Mantle Cell Lymphoma (MCL) treatment, covering topics like BTK inhibitors, unmet clinical needs, and the role of BTKis in transplant-eligible patients. Don’t miss the chance to participate in audience Q&A sessions and hear about key abstracts at SOHO 2023 and ASH 2023.
Simultaneously, join the “A Master Class in Personalized Myelofibrosis Care” session in the San Diego Ballroom AB. Learn about improving outcomes for patients with Myelofibrosis, recognizing patterns of suboptimal responses, and exploring the future of Myelofibrosis treatment.
Afternoon Sessions (3:00 PM – 5:30 PM PT)
In the afternoon, dive into “AL Amyloidosis: Advancements and Future Trends on Diagnosis and Individualized Treatment Approaches.” This session will cover the biology, clinical presentation, diagnostic approaches, and treatment guidelines for AL amyloidosis. Explore the evolving management algorithms for both newly diagnosed and relapsed patients, and get a sneak peek at key abstracts from ASH 2023.
Meanwhile, the “Advances in Autoimmune Hemolytic Anemia” session in San Diego Ballroom AB will unravel the complexities of Cold Agglutinin Disease (CAD). Delve into the pathophysiology, diagnostic criteria, current therapeutic options, and future directions in managing CAD.
Finally, the “An Expert Guide to What’s New and What’s Next for Novel Targeted Therapies in Relapsed/Refractory Follicular Lymphoma” session in Pacific Ballroom 18-19 will provide valuable insights into the latest treatment options for Follicular Lymphoma, including bispecific antibodies, epigenetic modifiers, PI3K inhibitors, and CAR T-cell therapy.
Featured Faculty
Our symposia feature a stellar lineup of experts in the field, including:
Abdulraheem Yacoub, MD
Professor of Medicine
The University of Kansas Cancer Center
Kansas City, Kansas
Angela Dispenzieri, MD
Consultant
Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine
Mayo Clinic
Rochester, Minnesota
Ann LaCasce, MD, MMSc
Associate Professor of Medicine
Lymphoma Program
Dana-Farber Cancer Institute
Boston, Massachusetts
Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM
Professor of Medicine and Haematology
University College London
Honorary Consultant Haematologist
University College Hospitals
Director, Jack O’Neil Laboratory
Department of Haematology
National Amyloidosis Centre
London, United Kingdom
Brian Hill, MD, PhD
Director, Lymphoid Malignancies Program
Staff Physician, Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio
Catherine M. Broome, MD
Associate Professor of Medicine
Lombardi Cancer Center
MedStar Georgetown University
Washington, DC
Danielle Brander, MD
Assistant Professor of Medicine
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina
David Dingli, MD, PhD
Professor of Medicine
Division of Hematology
Mayo Clinic College of Science and Medicine
Rochester, Minnesota
Deborah Stephens, DO
Associate Professor
Director of the CLL Program
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, North Carolina
Deva Sharma, MD, MS
Assistant Professor of Pathology, Microbiology, and Immunology
Vanderbilt University Medical Center
Nashville, TN
Jean-Jacques Kiladjian, MD, PhD
Professor
Department of Clinical Pharmacology
Université de Paris
Professor
Clinical Investigations Center
Saint-Louis Hospital
Paris, France
John P. Leonard, MD
Senior Associate Dean for Innovation and Initiatives
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York
Julie Vose, MD
Neumann M. and Mildred E. Harris Professor
Chief, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska
Matthew Lunning, DO, FACP
Associate Professor
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska
Peter Martin, MD
Associate Professor of Medicine
Department of Medicine, Division of Hematology-Oncology
Weill Cornell Medical College
New York, New York
Sonali Smith, MD, FASCO
Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
The University of Chicago
Chicago, Illinois
These esteemed faculty members bring a wealth of expertise to the hematology symposia, ensuring that attendees receive the latest and most valuable insights in the field.
Accreditation
Clinical Care Options is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Review the registration page for accreditation information.
We aim to provide healthcare professionals with the latest updates and insights to improve patient care.
Support
These valuable educational sessions are supported through educational grants from:
Alexion Pharmaceuticals, Genentech, a member of the Roche Group, Genmab
Ipsen Biopharmaceuticals, Inc., Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC,
Prothena Biosciences Limited, Regeneron Pharmaceuticals, Inc. and Sanofi.
Conclusion
Don’t miss this exciting opportunity to immerse yourself in the world of hematology breakthroughs and connect with fellow healthcare professionals and experts. Join us on December 8th, 2023, in sunny San Diego, and be part of these informative sessions that promise to advance your knowledge in hematology. Register now to secure your spot and be part of this extraordinary event. We look forward to seeing you there!